1. Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment
   Cristina Borzi et al, 2020, Pharmaceuticals CrossRef
2. STK11/LKB1 Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact
   Elvire Pons-Tostivint et al, 2021, Cells CrossRef
3. Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma Model
   Amanda Vannitamby et al, 2021, Cancers CrossRef
4. A novel 7 RNA-based signature for prediction of prognosis and therapeutic responses of wild-type BRAF cutaneous melanoma
   Ruizheng Sun et al, 2022, Biological Procedures Online CrossRef
5. LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress–Based Treatments
   Cristina Borzi et al, 2021, Journal of Thoracic Oncology CrossRef
6. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma
   Wuzhen Chen et al, 2020, Aging CrossRef
7. LKB1 expression and the prognosis of lung cancer
   Chunxuan Lin et al, 2021, Medicine CrossRef
8. Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta‐analysis
   Yu Guo et al, 2019, Journal of Cellular Physiology CrossRef
9. Hotspots and trends in liver kinase B1 research: A bibliometric analysis
   Yaowen Song et al, 2021, PLOS ONE CrossRef
10. LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer
    Eleni D. Lagoudaki et al, 2024, Cancers CrossRef